nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—atherosclerosis—type 2 diabetes mellitus	0.363	0.649	CtDrD
Niacin—coronary artery disease—type 2 diabetes mellitus	0.196	0.351	CtDrD
Niacin—SLC16A1—Nateglinide—type 2 diabetes mellitus	0.0884	0.391	CbGbCtD
Niacin—SLCO2B1—Tolbutamide—type 2 diabetes mellitus	0.0654	0.289	CbGbCtD
Niacin—SLCO2B1—Glyburide—type 2 diabetes mellitus	0.0376	0.166	CbGbCtD
Niacin—HCAR2—brown adipose tissue—type 2 diabetes mellitus	0.0113	0.3	CbGeAlD
Niacin—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0102	0.0453	CbGbCtD
Niacin—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00945	0.0418	CbGbCtD
Niacin—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00776	0.0343	CbGbCtD
Niacin—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00744	0.0329	CbGbCtD
Niacin—HCAR3—pancreas—type 2 diabetes mellitus	0.00253	0.0675	CbGeAlD
Niacin—QPRT—kidney—type 2 diabetes mellitus	0.00201	0.0537	CbGeAlD
Niacin—HCAR2—pancreas—type 2 diabetes mellitus	0.00167	0.0447	CbGeAlD
Niacin—HCAR2—adipose tissue—type 2 diabetes mellitus	0.00152	0.0405	CbGeAlD
Niacin—NNMT—islet of Langerhans—type 2 diabetes mellitus	0.00134	0.0358	CbGeAlD
Niacin—QPRT—liver—type 2 diabetes mellitus	0.00127	0.0339	CbGeAlD
Niacin—NNMT—nephron tubule—type 2 diabetes mellitus	0.00108	0.0288	CbGeAlD
Niacin—NNMT—cardiovascular system—type 2 diabetes mellitus	0.000969	0.0259	CbGeAlD
Niacin—NNMT—kidney—type 2 diabetes mellitus	0.000948	0.0253	CbGeAlD
Niacin—NNMT—pancreas—type 2 diabetes mellitus	0.000942	0.0251	CbGeAlD
Niacin—NNMT—cortex of kidney—type 2 diabetes mellitus	0.000923	0.0246	CbGeAlD
Niacin—SLC16A3—islet of Langerhans—type 2 diabetes mellitus	0.000915	0.0244	CbGeAlD
Niacin—NNMT—adipose tissue—type 2 diabetes mellitus	0.000854	0.0228	CbGeAlD
Niacin—SLC16A3—retina—type 2 diabetes mellitus	0.000782	0.0209	CbGeAlD
Niacin—Metyrapone—CYP2E1—type 2 diabetes mellitus	0.000664	0.494	CrCbGaD
Niacin—SLC16A3—cardiovascular system—type 2 diabetes mellitus	0.000662	0.0177	CbGeAlD
Niacin—SLC16A3—kidney—type 2 diabetes mellitus	0.000647	0.0173	CbGeAlD
Niacin—SLC16A3—pancreas—type 2 diabetes mellitus	0.000643	0.0172	CbGeAlD
Niacin—SLC16A3—cortex of kidney—type 2 diabetes mellitus	0.000631	0.0168	CbGeAlD
Niacin—NNMT—liver—type 2 diabetes mellitus	0.000599	0.016	CbGeAlD
Niacin—SLC16A3—adipose tissue—type 2 diabetes mellitus	0.000584	0.0156	CbGeAlD
Niacin—SLC16A1—retina—type 2 diabetes mellitus	0.000475	0.0127	CbGeAlD
Niacin—Metyrapone—CYP3A4—type 2 diabetes mellitus	0.000418	0.311	CrCbGaD
Niacin—SLC16A3—liver—type 2 diabetes mellitus	0.000409	0.0109	CbGeAlD
Niacin—SLC16A1—cardiovascular system—type 2 diabetes mellitus	0.000402	0.0107	CbGeAlD
Niacin—SLC16A1—kidney—type 2 diabetes mellitus	0.000393	0.0105	CbGeAlD
Niacin—SLC16A1—adipose tissue—type 2 diabetes mellitus	0.000354	0.00946	CbGeAlD
Niacin—SLCO2B1—kidney—type 2 diabetes mellitus	0.000338	0.00903	CbGeAlD
Niacin—SLCO2B1—adipose tissue—type 2 diabetes mellitus	0.000305	0.00814	CbGeAlD
Niacin—SLC22A5—retina—type 2 diabetes mellitus	0.000272	0.00725	CbGeAlD
Niacin—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000256	0.00683	CbGeAlD
Niacin—SLC16A1—liver—type 2 diabetes mellitus	0.000249	0.00664	CbGeAlD
Niacin—SLC22A5—kidney—type 2 diabetes mellitus	0.000225	0.006	CbGeAlD
Niacin—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000219	0.00584	CbGeAlD
Niacin—SLCO2B1—liver—type 2 diabetes mellitus	0.000214	0.00571	CbGeAlD
Niacin—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000203	0.00541	CbGeAlD
Niacin—CYP2D6—kidney—type 2 diabetes mellitus	0.000145	0.00387	CbGeAlD
Niacin—SLC22A5—liver—type 2 diabetes mellitus	0.000142	0.00379	CbGeAlD
Niacin—Salicylic acid—PTGS2—type 2 diabetes mellitus	0.000138	0.103	CrCbGaD
Niacin—Salicylic acid—ALB—type 2 diabetes mellitus	0.000123	0.0915	CrCbGaD
Niacin—CYP2D6—liver—type 2 diabetes mellitus	9.17e-05	0.00245	CbGeAlD
Niacin—Abdominal pain—Glyburide—type 2 diabetes mellitus	5.66e-05	0.000562	CcSEcCtD
Niacin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	5.66e-05	0.000561	CcSEcCtD
Niacin—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	5.65e-05	0.00056	CcSEcCtD
Niacin—Anorexia—Valsartan—type 2 diabetes mellitus	5.63e-05	0.000559	CcSEcCtD
Niacin—Muscle spasms—Losartan—type 2 diabetes mellitus	5.63e-05	0.000558	CcSEcCtD
Niacin—Asthenia—Bromocriptine—type 2 diabetes mellitus	5.62e-05	0.000558	CcSEcCtD
Niacin—Myalgia—Metformin—type 2 diabetes mellitus	5.61e-05	0.000557	CcSEcCtD
Niacin—Vertigo—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000554	CcSEcCtD
Niacin—Headache—Pioglitazone—type 2 diabetes mellitus	5.59e-05	0.000554	CcSEcCtD
Niacin—Syncope—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000553	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	5.58e-05	0.000553	CcSEcCtD
Niacin—Leukopenia—Irbesartan—type 2 diabetes mellitus	5.57e-05	0.000552	CcSEcCtD
Niacin—Visual impairment—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000551	CcSEcCtD
Niacin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	5.55e-05	0.000551	CcSEcCtD
Niacin—Nausea—Glipizide—type 2 diabetes mellitus	5.53e-05	0.000548	CcSEcCtD
Niacin—Vomiting—Glimepiride—type 2 diabetes mellitus	5.52e-05	0.000548	CcSEcCtD
Niacin—Hypotension—Valsartan—type 2 diabetes mellitus	5.52e-05	0.000548	CcSEcCtD
Niacin—Vision blurred—Losartan—type 2 diabetes mellitus	5.52e-05	0.000547	CcSEcCtD
Niacin—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.51e-05	0.000546	CcSEcCtD
Niacin—Pain—Gliclazide—type 2 diabetes mellitus	5.5e-05	0.000545	CcSEcCtD
Niacin—Rash—Glimepiride—type 2 diabetes mellitus	5.48e-05	0.000543	CcSEcCtD
Niacin—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.47e-05	0.000543	CcSEcCtD
Niacin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000542	CcSEcCtD
Niacin—Rash—Sitagliptin—type 2 diabetes mellitus	5.46e-05	0.000541	CcSEcCtD
Niacin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.45e-05	0.000541	CcSEcCtD
Niacin—Headache—Glimepiride—type 2 diabetes mellitus	5.44e-05	0.00054	CcSEcCtD
Niacin—Cough—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000539	CcSEcCtD
Niacin—Headache—Sitagliptin—type 2 diabetes mellitus	5.42e-05	0.000538	CcSEcCtD
Niacin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.38e-05	0.000534	CcSEcCtD
Niacin—Oedema—Metformin—type 2 diabetes mellitus	5.38e-05	0.000534	CcSEcCtD
Niacin—Tinnitus—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000533	CcSEcCtD
Niacin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.36e-05	0.000532	CcSEcCtD
Niacin—Flushing—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000531	CcSEcCtD
Niacin—Angioedema—Losartan—type 2 diabetes mellitus	5.35e-05	0.000531	CcSEcCtD
Niacin—Insomnia—Valsartan—type 2 diabetes mellitus	5.34e-05	0.00053	CcSEcCtD
Niacin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.32e-05	0.000528	CcSEcCtD
Niacin—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.31e-05	0.000526	CcSEcCtD
Niacin—Myalgia—Irbesartan—type 2 diabetes mellitus	5.3e-05	0.000525	CcSEcCtD
Niacin—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.3e-05	0.000525	CcSEcCtD
Niacin—Shock—Metformin—type 2 diabetes mellitus	5.29e-05	0.000525	CcSEcCtD
Niacin—Insomnia—Orlistat—type 2 diabetes mellitus	5.28e-05	0.000524	CcSEcCtD
Niacin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.28e-05	0.000523	CcSEcCtD
Niacin—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000522	CcSEcCtD
Niacin—Vertigo—Losartan—type 2 diabetes mellitus	5.26e-05	0.000522	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.26e-05	0.000522	CcSEcCtD
Niacin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.26e-05	0.000522	CcSEcCtD
Niacin—Somnolence—Valsartan—type 2 diabetes mellitus	5.25e-05	0.000521	CcSEcCtD
Niacin—Syncope—Losartan—type 2 diabetes mellitus	5.25e-05	0.000521	CcSEcCtD
Niacin—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.24e-05	0.00052	CcSEcCtD
Niacin—Leukopenia—Losartan—type 2 diabetes mellitus	5.24e-05	0.00052	CcSEcCtD
Niacin—Skin disorder—Metformin—type 2 diabetes mellitus	5.23e-05	0.000518	CcSEcCtD
Niacin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.2e-05	0.000516	CcSEcCtD
Niacin—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.2e-05	0.000516	CcSEcCtD
Niacin—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.18e-05	0.000514	CcSEcCtD
Niacin—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000514	CcSEcCtD
Niacin—Palpitations—Losartan—type 2 diabetes mellitus	5.18e-05	0.000513	CcSEcCtD
Niacin—Nausea—Glimepiride—type 2 diabetes mellitus	5.16e-05	0.000512	CcSEcCtD
Niacin—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000511	CcSEcCtD
Niacin—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.15e-05	0.00051	CcSEcCtD
Niacin—Nausea—Sitagliptin—type 2 diabetes mellitus	5.14e-05	0.00051	CcSEcCtD
Niacin—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.14e-05	0.00051	CcSEcCtD
Niacin—Asthenia—Glyburide—type 2 diabetes mellitus	5.14e-05	0.00051	CcSEcCtD
Niacin—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.14e-05	0.000509	CcSEcCtD
Niacin—Anorexia—Metformin—type 2 diabetes mellitus	5.13e-05	0.000509	CcSEcCtD
Niacin—Cough—Losartan—type 2 diabetes mellitus	5.11e-05	0.000507	CcSEcCtD
Niacin—Urticaria—Gliclazide—type 2 diabetes mellitus	5.11e-05	0.000507	CcSEcCtD
Niacin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.1e-05	0.000506	CcSEcCtD
Niacin—Alopecia—Ramipril—type 2 diabetes mellitus	5.1e-05	0.000506	CcSEcCtD
Niacin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.08e-05	0.000504	CcSEcCtD
Niacin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.08e-05	0.000504	CcSEcCtD
Niacin—Oedema—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.000504	CcSEcCtD
Niacin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.000504	CcSEcCtD
Niacin—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.08e-05	0.000503	CcSEcCtD
Niacin—Pruritus—Glyburide—type 2 diabetes mellitus	5.07e-05	0.000503	CcSEcCtD
Niacin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.04e-05	0.0005	CcSEcCtD
Niacin—Hypotension—Metformin—type 2 diabetes mellitus	5.03e-05	0.000499	CcSEcCtD
Niacin—Erythema—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000498	CcSEcCtD
Niacin—Malnutrition—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000498	CcSEcCtD
Niacin—Shock—Irbesartan—type 2 diabetes mellitus	5e-05	0.000496	CcSEcCtD
Niacin—Pain—Orlistat—type 2 diabetes mellitus	4.99e-05	0.000495	CcSEcCtD
Niacin—Arthralgia—Losartan—type 2 diabetes mellitus	4.99e-05	0.000494	CcSEcCtD
Niacin—Myalgia—Losartan—type 2 diabetes mellitus	4.99e-05	0.000494	CcSEcCtD
Niacin—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.98e-05	0.000494	CcSEcCtD
Niacin—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000492	CcSEcCtD
Niacin—Rash—Bromocriptine—type 2 diabetes mellitus	4.94e-05	0.00049	CcSEcCtD
Niacin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.94e-05	0.00049	CcSEcCtD
Niacin—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000489	CcSEcCtD
Niacin—Tension—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000489	CcSEcCtD
Niacin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.91e-05	0.000487	CcSEcCtD
Niacin—Headache—Bromocriptine—type 2 diabetes mellitus	4.91e-05	0.000487	CcSEcCtD
Niacin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.9e-05	0.000486	CcSEcCtD
Niacin—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.9e-05	0.000486	CcSEcCtD
Niacin—Nervousness—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000484	CcSEcCtD
Niacin—Dry mouth—Losartan—type 2 diabetes mellitus	4.88e-05	0.000484	CcSEcCtD
Niacin—Anorexia—Irbesartan—type 2 diabetes mellitus	4.84e-05	0.00048	CcSEcCtD
Niacin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.83e-05	0.000479	CcSEcCtD
Niacin—Paraesthesia—Metformin—type 2 diabetes mellitus	4.83e-05	0.000479	CcSEcCtD
Niacin—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000479	CcSEcCtD
Niacin—Dyspnoea—Metformin—type 2 diabetes mellitus	4.8e-05	0.000476	CcSEcCtD
Niacin—Somnolence—Metformin—type 2 diabetes mellitus	4.78e-05	0.000474	CcSEcCtD
Niacin—Oedema—Losartan—type 2 diabetes mellitus	4.78e-05	0.000474	CcSEcCtD
Niacin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.78e-05	0.000474	CcSEcCtD
Niacin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.77e-05	0.000474	CcSEcCtD
Niacin—Hypotension—Irbesartan—type 2 diabetes mellitus	4.75e-05	0.000471	CcSEcCtD
Niacin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.74e-05	0.00047	CcSEcCtD
Niacin—Dyspepsia—Metformin—type 2 diabetes mellitus	4.74e-05	0.00047	CcSEcCtD
Niacin—Shock—Losartan—type 2 diabetes mellitus	4.7e-05	0.000466	CcSEcCtD
Niacin—Urticaria—Valsartan—type 2 diabetes mellitus	4.69e-05	0.000466	CcSEcCtD
Niacin—Decreased appetite—Metformin—type 2 diabetes mellitus	4.68e-05	0.000464	CcSEcCtD
Niacin—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.67e-05	0.000463	CcSEcCtD
Niacin—Tachycardia—Losartan—type 2 diabetes mellitus	4.66e-05	0.000463	CcSEcCtD
Niacin—Nausea—Bromocriptine—type 2 diabetes mellitus	4.65e-05	0.000462	CcSEcCtD
Niacin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.65e-05	0.000461	CcSEcCtD
Niacin—Urticaria—Orlistat—type 2 diabetes mellitus	4.64e-05	0.00046	CcSEcCtD
Niacin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000459	CcSEcCtD
Niacin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.62e-05	0.000458	CcSEcCtD
Niacin—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.62e-05	0.000458	CcSEcCtD
Niacin—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.62e-05	0.000458	CcSEcCtD
Niacin—Asthenia—Gliclazide—type 2 diabetes mellitus	4.61e-05	0.000458	CcSEcCtD
Niacin—Angioedema—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000455	CcSEcCtD
Niacin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000452	CcSEcCtD
Niacin—Anorexia—Losartan—type 2 diabetes mellitus	4.56e-05	0.000452	CcSEcCtD
Niacin—Vomiting—Glyburide—type 2 diabetes mellitus	4.55e-05	0.000452	CcSEcCtD
Niacin—Pruritus—Gliclazide—type 2 diabetes mellitus	4.55e-05	0.000451	CcSEcCtD
Niacin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000449	CcSEcCtD
Niacin—Rash—Glyburide—type 2 diabetes mellitus	4.52e-05	0.000448	CcSEcCtD
Niacin—Somnolence—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000448	CcSEcCtD
Niacin—Dermatitis—Glyburide—type 2 diabetes mellitus	4.51e-05	0.000447	CcSEcCtD
Niacin—Vertigo—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000447	CcSEcCtD
Niacin—Syncope—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000447	CcSEcCtD
Niacin—Leukopenia—Ramipril—type 2 diabetes mellitus	4.49e-05	0.000446	CcSEcCtD
Niacin—Headache—Glyburide—type 2 diabetes mellitus	4.49e-05	0.000445	CcSEcCtD
Niacin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.47e-05	0.000443	CcSEcCtD
Niacin—Hypotension—Losartan—type 2 diabetes mellitus	4.47e-05	0.000443	CcSEcCtD
Niacin—Palpitations—Ramipril—type 2 diabetes mellitus	4.44e-05	0.00044	CcSEcCtD
Niacin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.41e-05	0.000438	CcSEcCtD
Niacin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000438	CcSEcCtD
Niacin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.4e-05	0.000436	CcSEcCtD
Niacin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.4e-05	0.000436	CcSEcCtD
Niacin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.38e-05	0.000435	CcSEcCtD
Niacin—Cough—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000435	CcSEcCtD
Niacin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.35e-05	0.000432	CcSEcCtD
Niacin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.35e-05	0.000432	CcSEcCtD
Niacin—Pain—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000431	CcSEcCtD
Niacin—Insomnia—Losartan—type 2 diabetes mellitus	4.32e-05	0.000429	CcSEcCtD
Niacin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.3e-05	0.000427	CcSEcCtD
Niacin—Paraesthesia—Losartan—type 2 diabetes mellitus	4.29e-05	0.000426	CcSEcCtD
Niacin—Urticaria—Metformin—type 2 diabetes mellitus	4.28e-05	0.000424	CcSEcCtD
Niacin—Myalgia—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000424	CcSEcCtD
Niacin—Arthralgia—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000424	CcSEcCtD
Niacin—Dyspnoea—Losartan—type 2 diabetes mellitus	4.26e-05	0.000423	CcSEcCtD
Niacin—Nausea—Glyburide—type 2 diabetes mellitus	4.25e-05	0.000422	CcSEcCtD
Niacin—Abdominal pain—Metformin—type 2 diabetes mellitus	4.25e-05	0.000422	CcSEcCtD
Niacin—Dizziness—Gliclazide—type 2 diabetes mellitus	4.25e-05	0.000422	CcSEcCtD
Niacin—Somnolence—Losartan—type 2 diabetes mellitus	4.25e-05	0.000421	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000421	CcSEcCtD
Niacin—Asthenia—Valsartan—type 2 diabetes mellitus	4.24e-05	0.00042	CcSEcCtD
Niacin—Dyspepsia—Losartan—type 2 diabetes mellitus	4.21e-05	0.000417	CcSEcCtD
Niacin—Asthenia—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000415	CcSEcCtD
Niacin—Pruritus—Valsartan—type 2 diabetes mellitus	4.18e-05	0.000415	CcSEcCtD
Niacin—Dry mouth—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000415	CcSEcCtD
Niacin—Decreased appetite—Losartan—type 2 diabetes mellitus	4.15e-05	0.000412	CcSEcCtD
Niacin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000412	CcSEcCtD
Niacin—Pruritus—Orlistat—type 2 diabetes mellitus	4.13e-05	0.00041	CcSEcCtD
Niacin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000406	CcSEcCtD
Niacin—Oedema—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000406	CcSEcCtD
Niacin—Vomiting—Gliclazide—type 2 diabetes mellitus	4.09e-05	0.000406	CcSEcCtD
Niacin—Pain—Losartan—type 2 diabetes mellitus	4.09e-05	0.000405	CcSEcCtD
Niacin—Rash—Gliclazide—type 2 diabetes mellitus	4.06e-05	0.000402	CcSEcCtD
Niacin—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.05e-05	0.000402	CcSEcCtD
Niacin—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.04e-05	0.000401	CcSEcCtD
Niacin—Urticaria—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.0004	CcSEcCtD
Niacin—Shock—Ramipril—type 2 diabetes mellitus	4.03e-05	0.0004	CcSEcCtD
Niacin—Headache—Gliclazide—type 2 diabetes mellitus	4.03e-05	0.0004	CcSEcCtD
Niacin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000398	CcSEcCtD
Niacin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000398	CcSEcCtD
Niacin—Tachycardia—Ramipril—type 2 diabetes mellitus	4e-05	0.000397	CcSEcCtD
Niacin—Diarrhoea—Orlistat—type 2 diabetes mellitus	4e-05	0.000396	CcSEcCtD
Niacin—Skin disorder—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000395	CcSEcCtD
Niacin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000393	CcSEcCtD
Niacin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.91e-05	0.000388	CcSEcCtD
Niacin—Dizziness—Valsartan—type 2 diabetes mellitus	3.91e-05	0.000388	CcSEcCtD
Niacin—Anorexia—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000387	CcSEcCtD
Niacin—Dizziness—Orlistat—type 2 diabetes mellitus	3.86e-05	0.000383	CcSEcCtD
Niacin—Asthenia—Metformin—type 2 diabetes mellitus	3.86e-05	0.000383	CcSEcCtD
Niacin—Hypotension—Ramipril—type 2 diabetes mellitus	3.83e-05	0.00038	CcSEcCtD
Niacin—Nausea—Gliclazide—type 2 diabetes mellitus	3.82e-05	0.000379	CcSEcCtD
Niacin—Pruritus—Metformin—type 2 diabetes mellitus	3.81e-05	0.000378	CcSEcCtD
Niacin—Urticaria—Losartan—type 2 diabetes mellitus	3.8e-05	0.000377	CcSEcCtD
Niacin—Abdominal pain—Losartan—type 2 diabetes mellitus	3.78e-05	0.000375	CcSEcCtD
Niacin—Body temperature increased—Losartan—type 2 diabetes mellitus	3.78e-05	0.000375	CcSEcCtD
Niacin—Vomiting—Valsartan—type 2 diabetes mellitus	3.76e-05	0.000373	CcSEcCtD
Niacin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000371	CcSEcCtD
Niacin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.73e-05	0.00037	CcSEcCtD
Niacin—Rash—Valsartan—type 2 diabetes mellitus	3.73e-05	0.00037	CcSEcCtD
Niacin—Dermatitis—Valsartan—type 2 diabetes mellitus	3.72e-05	0.000369	CcSEcCtD
Niacin—Vomiting—Orlistat—type 2 diabetes mellitus	3.71e-05	0.000368	CcSEcCtD
Niacin—Insomnia—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000368	CcSEcCtD
Niacin—Headache—Valsartan—type 2 diabetes mellitus	3.7e-05	0.000367	CcSEcCtD
Niacin—Diarrhoea—Metformin—type 2 diabetes mellitus	3.68e-05	0.000365	CcSEcCtD
Niacin—Rash—Orlistat—type 2 diabetes mellitus	3.68e-05	0.000365	CcSEcCtD
Niacin—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000365	CcSEcCtD
Niacin—Dermatitis—Orlistat—type 2 diabetes mellitus	3.68e-05	0.000365	CcSEcCtD
Niacin—Headache—Orlistat—type 2 diabetes mellitus	3.66e-05	0.000363	CcSEcCtD
Niacin—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000362	CcSEcCtD
Niacin—Asthenia—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000361	CcSEcCtD
Niacin—Somnolence—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000361	CcSEcCtD
Niacin—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000358	CcSEcCtD
Niacin—Pruritus—Irbesartan—type 2 diabetes mellitus	3.59e-05	0.000356	CcSEcCtD
Niacin—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000353	CcSEcCtD
Niacin—Dizziness—Metformin—type 2 diabetes mellitus	3.56e-05	0.000353	CcSEcCtD
Niacin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000351	CcSEcCtD
Niacin—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.52e-05	0.000349	CcSEcCtD
Niacin—Nausea—Valsartan—type 2 diabetes mellitus	3.51e-05	0.000348	CcSEcCtD
Niacin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.47e-05	0.000345	CcSEcCtD
Niacin—Nausea—Orlistat—type 2 diabetes mellitus	3.47e-05	0.000344	CcSEcCtD
Niacin—Asthenia—Losartan—type 2 diabetes mellitus	3.43e-05	0.00034	CcSEcCtD
Niacin—Vomiting—Metformin—type 2 diabetes mellitus	3.42e-05	0.000339	CcSEcCtD
Niacin—Rash—Metformin—type 2 diabetes mellitus	3.39e-05	0.000337	CcSEcCtD
Niacin—Dermatitis—Metformin—type 2 diabetes mellitus	3.39e-05	0.000336	CcSEcCtD
Niacin—Pruritus—Losartan—type 2 diabetes mellitus	3.38e-05	0.000335	CcSEcCtD
Niacin—Headache—Metformin—type 2 diabetes mellitus	3.37e-05	0.000334	CcSEcCtD
Niacin—Dizziness—Irbesartan—type 2 diabetes mellitus	3.36e-05	0.000333	CcSEcCtD
Niacin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000332	CcSEcCtD
Niacin—Diarrhoea—Losartan—type 2 diabetes mellitus	3.27e-05	0.000324	CcSEcCtD
Niacin—Urticaria—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000323	CcSEcCtD
Niacin—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000321	CcSEcCtD
Niacin—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000321	CcSEcCtD
Niacin—Vomiting—Irbesartan—type 2 diabetes mellitus	3.23e-05	0.00032	CcSEcCtD
Niacin—Rash—Irbesartan—type 2 diabetes mellitus	3.2e-05	0.000318	CcSEcCtD
Niacin—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.2e-05	0.000317	CcSEcCtD
Niacin—Nausea—Metformin—type 2 diabetes mellitus	3.2e-05	0.000317	CcSEcCtD
Niacin—Headache—Irbesartan—type 2 diabetes mellitus	3.18e-05	0.000316	CcSEcCtD
Niacin—Dizziness—Losartan—type 2 diabetes mellitus	3.16e-05	0.000313	CcSEcCtD
Niacin—Vomiting—Losartan—type 2 diabetes mellitus	3.04e-05	0.000301	CcSEcCtD
Niacin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000299	CcSEcCtD
Niacin—Nausea—Irbesartan—type 2 diabetes mellitus	3.02e-05	0.000299	CcSEcCtD
Niacin—Rash—Losartan—type 2 diabetes mellitus	3.01e-05	0.000299	CcSEcCtD
Niacin—Dermatitis—Losartan—type 2 diabetes mellitus	3.01e-05	0.000299	CcSEcCtD
Niacin—Headache—Losartan—type 2 diabetes mellitus	2.99e-05	0.000297	CcSEcCtD
Niacin—Asthenia—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000292	CcSEcCtD
Niacin—Pruritus—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000288	CcSEcCtD
Niacin—Nausea—Losartan—type 2 diabetes mellitus	2.84e-05	0.000282	CcSEcCtD
Niacin—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.8e-05	0.000278	CcSEcCtD
Niacin—Dizziness—Ramipril—type 2 diabetes mellitus	2.71e-05	0.000269	CcSEcCtD
Niacin—Vomiting—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000258	CcSEcCtD
Niacin—Rash—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000256	CcSEcCtD
Niacin—Dermatitis—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000256	CcSEcCtD
Niacin—Headache—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000255	CcSEcCtD
Niacin—Nausea—Ramipril—type 2 diabetes mellitus	2.43e-05	0.000241	CcSEcCtD
Niacin—NNMT—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-05	0.00015	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1A2—type 2 diabetes mellitus	1.13e-05	0.000149	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	1.12e-05	0.000148	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MMP1—type 2 diabetes mellitus	1.11e-05	0.000147	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HK1—type 2 diabetes mellitus	1.11e-05	0.000147	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	1.11e-05	0.000147	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—INS—type 2 diabetes mellitus	1.11e-05	0.000147	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.1e-05	0.000146	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SRC—type 2 diabetes mellitus	1.1e-05	0.000146	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.1e-05	0.000145	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP3A4—type 2 diabetes mellitus	1.1e-05	0.000145	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.09e-05	0.000144	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.09e-05	0.000144	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	1.08e-05	0.000143	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—CALM1—type 2 diabetes mellitus	1.08e-05	0.000143	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—type 2 diabetes mellitus	1.07e-05	0.000142	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.07e-05	0.000142	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.07e-05	0.000142	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LPA—type 2 diabetes mellitus	1.07e-05	0.000142	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GCKR—type 2 diabetes mellitus	1.07e-05	0.000142	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.07e-05	0.000142	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.07e-05	0.000142	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.07e-05	0.000141	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—APOA1—type 2 diabetes mellitus	1.06e-05	0.00014	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.06e-05	0.00014	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GNB3—type 2 diabetes mellitus	1.06e-05	0.00014	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—HMOX1—type 2 diabetes mellitus	1.05e-05	0.000139	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—INS—type 2 diabetes mellitus	1.05e-05	0.000139	CbGpPWpGaD
Niacin—QPRT—Disease—TGFB1—type 2 diabetes mellitus	1.05e-05	0.000139	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.05e-05	0.000139	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.04e-05	0.000138	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CAT—type 2 diabetes mellitus	1.04e-05	0.000137	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.04e-05	0.000137	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.04e-05	0.000137	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.03e-05	0.000137	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—type 2 diabetes mellitus	1.03e-05	0.000136	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALDOB—type 2 diabetes mellitus	1.03e-05	0.000136	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.02e-05	0.000135	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.02e-05	0.000134	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.02e-05	0.000134	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PRKCB—type 2 diabetes mellitus	1.01e-05	0.000134	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.01e-05	0.000134	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOB—type 2 diabetes mellitus	1.01e-05	0.000133	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS2—type 2 diabetes mellitus	1e-05	0.000132	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1e-05	0.000132	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TGFB1—type 2 diabetes mellitus	9.86e-06	0.00013	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTM1—type 2 diabetes mellitus	9.81e-06	0.00013	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.81e-06	0.00013	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.73e-06	0.000129	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.73e-06	0.000129	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.66e-06	0.000128	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—LPL—type 2 diabetes mellitus	9.63e-06	0.000127	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GLP1R—type 2 diabetes mellitus	9.56e-06	0.000126	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ADCY5—type 2 diabetes mellitus	9.43e-06	0.000125	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GPX1—type 2 diabetes mellitus	9.39e-06	0.000124	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.35e-06	0.000123	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.23e-06	0.000122	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.23e-06	0.000122	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.2e-06	0.000122	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.16e-06	0.000121	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CD36—type 2 diabetes mellitus	9.15e-06	0.000121	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPP2CA—type 2 diabetes mellitus	9.03e-06	0.000119	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A2—type 2 diabetes mellitus	8.92e-06	0.000118	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF1—type 2 diabetes mellitus	8.88e-06	0.000117	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT2—type 2 diabetes mellitus	8.88e-06	0.000117	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CPT1A—type 2 diabetes mellitus	8.74e-06	0.000116	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTR—type 2 diabetes mellitus	8.74e-06	0.000116	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RELA—type 2 diabetes mellitus	8.69e-06	0.000115	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—type 2 diabetes mellitus	8.67e-06	0.000115	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—type 2 diabetes mellitus	8.63e-06	0.000114	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NAMPT—type 2 diabetes mellitus	8.57e-06	0.000113	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LIPC—type 2 diabetes mellitus	8.52e-06	0.000113	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HBA1—type 2 diabetes mellitus	8.52e-06	0.000113	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GCK—type 2 diabetes mellitus	8.52e-06	0.000113	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	8.51e-06	0.000112	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARA—type 2 diabetes mellitus	8.5e-06	0.000112	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP11A1—type 2 diabetes mellitus	8.47e-06	0.000112	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE1—type 2 diabetes mellitus	8.43e-06	0.000111	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.43e-06	0.000111	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—type 2 diabetes mellitus	8.42e-06	0.000111	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.34e-06	0.00011	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC9A1—type 2 diabetes mellitus	8.32e-06	0.00011	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.26e-06	0.000109	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AGT—type 2 diabetes mellitus	8.24e-06	0.000109	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CETP—type 2 diabetes mellitus	8.22e-06	0.000109	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.21e-06	0.000108	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.2e-06	0.000108	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CALM1—type 2 diabetes mellitus	8.1e-06	0.000107	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOE—type 2 diabetes mellitus	8.07e-06	0.000107	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS3—type 2 diabetes mellitus	8.05e-06	0.000106	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3R1—type 2 diabetes mellitus	8.05e-06	0.000106	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOA1—type 2 diabetes mellitus	7.98e-06	0.000105	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—type 2 diabetes mellitus	7.92e-06	0.000105	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.91e-06	0.000105	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.91e-06	0.000104	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.83e-06	0.000104	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.81e-06	0.000103	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.78e-06	0.000103	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.73e-06	0.000102	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PSMD6—type 2 diabetes mellitus	7.64e-06	0.000101	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SNAP25—type 2 diabetes mellitus	7.64e-06	0.000101	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SREBF1—type 2 diabetes mellitus	7.64e-06	0.000101	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.57e-06	0.0001	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CTGF—type 2 diabetes mellitus	7.5e-06	9.91e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMGCR—type 2 diabetes mellitus	7.43e-06	9.82e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.4e-06	9.78e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.32e-06	9.68e-05	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—type 2 diabetes mellitus	7.31e-06	9.66e-05	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.29e-06	9.63e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ADRA2A—type 2 diabetes mellitus	7.27e-06	9.61e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.2e-06	9.51e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.18e-06	9.49e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PPARG—type 2 diabetes mellitus	7.03e-06	9.29e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.01e-06	9.27e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.99e-06	9.24e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.91e-06	9.13e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.91e-06	9.13e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—INS—type 2 diabetes mellitus	6.89e-06	9.11e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—type 2 diabetes mellitus	6.86e-06	9.06e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SRC—type 2 diabetes mellitus	6.83e-06	9.02e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.74e-06	8.91e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.65e-06	8.78e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GCG—type 2 diabetes mellitus	6.63e-06	8.75e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.63e-06	8.75e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BHMT—type 2 diabetes mellitus	6.58e-06	8.69e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.44e-06	8.5e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—type 2 diabetes mellitus	6.32e-06	8.35e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.31e-06	8.34e-05	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.27e-06	8.28e-05	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—type 2 diabetes mellitus	6.12e-06	8.09e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.1e-06	8.06e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3R1—type 2 diabetes mellitus	6.05e-06	7.99e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NOS3—type 2 diabetes mellitus	6.05e-06	7.99e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.98e-06	7.9e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SRC—type 2 diabetes mellitus	5.96e-06	7.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—type 2 diabetes mellitus	5.8e-06	7.67e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AANAT—type 2 diabetes mellitus	5.75e-06	7.6e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGDS—type 2 diabetes mellitus	5.75e-06	7.6e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.71e-06	7.55e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GNB3—type 2 diabetes mellitus	5.71e-06	7.55e-05	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—type 2 diabetes mellitus	5.69e-06	7.52e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMOX1—type 2 diabetes mellitus	5.68e-06	7.51e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CAT—type 2 diabetes mellitus	5.61e-06	7.41e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—type 2 diabetes mellitus	5.53e-06	7.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	5.45e-06	7.2e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	5.45e-06	7.2e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOB—type 2 diabetes mellitus	5.45e-06	7.19e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—type 2 diabetes mellitus	5.33e-06	7.04e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—type 2 diabetes mellitus	5.3e-06	7e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	5.2e-06	6.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—LPL—type 2 diabetes mellitus	5.2e-06	6.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ADCY5—type 2 diabetes mellitus	5.09e-06	6.73e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GPX1—type 2 diabetes mellitus	5.07e-06	6.7e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CD36—type 2 diabetes mellitus	4.94e-06	6.53e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.88e-06	6.45e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.85e-06	6.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	4.8e-06	6.34e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	4.8e-06	6.34e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—type 2 diabetes mellitus	4.68e-06	6.19e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.64e-06	6.13e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	4.64e-06	6.13e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	4.64e-06	6.13e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	4.64e-06	6.13e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	4.64e-06	6.13e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.6e-06	6.07e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARA—type 2 diabetes mellitus	4.59e-06	6.07e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	4.49e-06	5.93e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.47e-06	5.91e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AGT—type 2 diabetes mellitus	4.45e-06	5.88e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CALM1—type 2 diabetes mellitus	4.37e-06	5.78e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOE—type 2 diabetes mellitus	4.36e-06	5.76e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOA1—type 2 diabetes mellitus	4.31e-06	5.69e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.24e-06	5.6e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	4.24e-06	5.6e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	4.24e-06	5.6e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	4.13e-06	5.46e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	3.94e-06	5.21e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	3.94e-06	5.21e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	3.94e-06	5.21e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PPARG—type 2 diabetes mellitus	3.8e-06	5.02e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	3.78e-06	4.99e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	3.78e-06	4.99e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—INS—type 2 diabetes mellitus	3.72e-06	4.92e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—type 2 diabetes mellitus	3.7e-06	4.89e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	3.64e-06	4.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	3.64e-06	4.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	3.57e-06	4.72e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	3.51e-06	4.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	3.51e-06	4.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	3.51e-06	4.64e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—type 2 diabetes mellitus	3.41e-06	4.51e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	3.3e-06	4.36e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NOS3—type 2 diabetes mellitus	3.27e-06	4.31e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.27e-06	4.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	3.09e-06	4.09e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	2.99e-06	3.95e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	2.99e-06	3.95e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	2.99e-06	3.95e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	2.99e-06	3.95e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.99e-06	3.95e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	2.86e-06	3.78e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—type 2 diabetes mellitus	2.78e-06	3.67e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	2.66e-06	3.52e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.49e-06	3.28e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.44e-06	3.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.44e-06	3.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.39e-06	3.16e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.37e-06	3.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.37e-06	3.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.37e-06	3.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.36e-06	3.12e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.32e-06	3.06e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.29e-06	3.03e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.13e-06	2.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.13e-06	2.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.13e-06	2.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.09e-06	2.76e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.07e-06	2.74e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2.03e-06	2.68e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.95e-06	2.57e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.93e-06	2.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.93e-06	2.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.88e-06	2.48e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.85e-06	2.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.85e-06	2.44e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.59e-06	2.1e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.59e-06	2.1e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.58e-06	2.09e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.56e-06	2.06e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.52e-06	2e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—type 2 diabetes mellitus	1.5e-06	1.98e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.48e-06	1.95e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.45e-06	1.91e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.42e-06	1.87e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.41e-06	1.87e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.38e-06	1.82e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.36e-06	1.8e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.3e-06	1.72e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.28e-06	1.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.24e-06	1.64e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.22e-06	1.61e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.21e-06	1.6e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.2e-06	1.59e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.06e-06	1.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.04e-06	1.37e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.51e-07	1.26e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.1e-07	1.2e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	9.1e-07	1.2e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.32e-07	1.1e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.18e-07	5.52e-06	CbGpPWpGaD
